AstraZeneca Articles
AstraZeneca appoints Simon Lowth as CFO
8 October 2007
UK stem cell research group launched
8 October 2007
FDA expands FluMist approval
8 October 2007
Europe leads surge in Pharma M&A deal values
1 October 2007
Patent expiries will reduce bipolar drug market $400M
1 October 2007
AstraZeneca buys Verus asthma program
1 October 2007
Speculation on UK drug major execs
1 October 2007
MedImmune licenses reverse genetics technology to GSK
27 September 2007
AstraZeneca and Keio University establish master study deal
27 September 2007
Stock Commentary - Europe - week to September 24, 2007
27 September 2007
Janssen and AstraZeneca drugs now lead antipsychotics
24 September 2007
AstraZeneca responds on outsourcing
24 September 2007
Small number of combination drugs reaching the Japanese market
24 September 2007
Drug sales up 5% in year to July 2007
24 September 2007
AstraZeneca places 750M-euro eurobond
24 September 2007
Stock Commentary - Europe - week to Sept 10, 2007
17 September 2007
MedImmune resolves FDA vacc plant concerns
17 September 2007
King Pharma returns bremelanotide rights to Palatin
17 September 2007
World Conference on Lung Cancer highlights important developments
17 September 2007
In vivo alternative launched by Biovator
17 September 2007
"Admonishment" for ApoPharma and AstraZeneca
17 September 2007
AstraZeneca completes $6.9B bond issue
10 September 2007
Stock Commentary - Europe - week to Sept 3, 2007
10 September 2007
Argenta swings to L8.9M profit in FY 2007
10 September 2007
Dual Crestor/ABT-335 pill to enter Ph III
10 September 2007
AstraZeneca sets up CPU unit in China
10 September 2007
USA's NIH updated asthma treatment guidelines welcomed by industry
10 September 2007
Stock Commentary - Europe - week to August 27, 2007
3 September 2007
Dutch approval for AstraZeneca's once-daily Seroquel XR
3 September 2007
US Court of Appeals endorses FDA pre-emption
3 September 2007
Pfizer-Wyeth merger speculation fuels debate
3 September 2007
Seroquel as effective as olanzapine in mania
3 September 2007
Abraxis gains expedited appro of generic cefotetan
20 August 2007
Attempt at drug funds transparency criticized
20 August 2007
Galapagos' 1st-half loss soars 204%
20 August 2007
US drug distribution market dominated by
13 August 2007
Japan's "New Vision" slammed by Pharma
13 August 2007
Sandoz debut generic Toprol in USA
13 August 2007
MedImmune begins Ph IIa asthma study
6 August 2007
Crestor boosts Shionogi 1st-qtr fiscal sales 8.7%
6 August 2007
Medarex partner initiates lupus Ab study
30 July 2007
Stock Commentary - Europe - week to July 23, 2007
30 July 2007
Stock Commentary - Europe - week to July 16, 2007
23 July 2007
Arimidex is "cost effective" on NICE model
23 July 2007
Drug Royalty buys FluMist royalties
16 July 2007
B-MS/Pfizer anti-clotting drug shows promise
16 July 2007
Silence Thera in $400M R&D deal with AstraZeneca
16 July 2007
Stock Commentary - Europe - week to July 2, 2007
9 July 2007
CORRECTION: AstraZeneca's Symbicort
9 July 2007
AstraZeneca's Symbicort available in the USA
2 July 2007
Peregrine in R&D deal with NIAID
25 June 2007
The Queen's Birthday Honors List
25 June 2007
48th GIRP AGM focuses on wholesale sector threats : loss of public service and fake drugs
25 June 2007
SMC approves AstraZeneca
18 June 2007
Almirall announces new appointments
18 June 2007
SMC clears Symbicort SMART for asthma
18 June 2007
AstraZeneca's CFO Jon Symonds leaves the firm
11 June 2007
Bondronat prevents bone loss in cancer patients
11 June 2007
AstraZeneca acquires Quebec plant from DSM
11 June 2007
Mylan wins generic omeprazole case
11 June 2007
AstraZeneca launches Symbicort SMART in UK
4 June 2007
MedImmune's FluMist sBLA makes progress
4 June 2007
Japan stock market week to May 21, 2007
28 May 2007
Sandoz gains FDA appro for generic Toprol
28 May 2007
FDA approves XR Seroquel for schizophrenia
28 May 2007
MedImmune's 1st-qtr profit triples on Synagis
21 May 2007
Stock Commentary - Europe - week to May 7, 2007
14 May 2007
Huge pay outs for MedImmune execs
14 May 2007
Japan stock market week to April 30, 2007
7 May 2007
AstraZeneca announces changes to senior team
30 April 2007
Stock Commentary - Europe - week to April 23, 2007
30 April 2007
Stock Commentary - New York week to April 23, 2007
30 April 2007
"Record number" of drugs in UK pipeline
30 April 2007
AstraZenca ends its deal with ArtheroGenics
30 April 2007
Mixed reaction to AstraZeneca acquisition
30 April 2007
BTG, Novacea and KuDOS sign AQ4N deal
30 April 2007
NMA and AstraZeneca partner on clinical trial education
30 April 2007
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
